Literature DB >> 16508208

Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats.

Akira Yabuki1, Tomonori Tahara, Kazuyuki Taniguchi, Mitsuharu Matsumoto, Shusaku Suzuki.   

Abstract

Neuronal nitric oxide synthase (nNOS) and cyclooxygenase-2 (COX-2) regulate the tubuloglomerular feedback (TGF) and renin-angiotensin system (RAS) in the kidney. In type 1 diabetic rats, renal overproduction of these enzymes and their relationship to the pathogenesis of diabetic nephropathy has been demonstrated. In the present study, we histologically and immunohistochemically investigated the kidneys of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, as a model of type 2 diabetes, at 62 weeks of age (chronic phase of diabetes). The kidneys of OLETF rats showed typical diabetic nephropathy. Quantitative scores for glomerulosclerosis and interstitial fibrosis in OLETF rats were significantly higher than those of age-matched control Long-Evans Tokushima Otsuka (LETO) rats. nNOS- and COX-2-positive immunoreactions were observed in the distal tubules and collecting ducts. These reactions appeared to be more widely distributed in OLETF, and the number of nNOS-and COX-2-positive sites in the OLETF were significantly more than those in LETO rats. Expression of renin, angiotensin II, and inducible nitric oxide synthase (iNOS) were also examined immunohistochemically, and no differences between OLETF and LETO rats were observed in the distributions and the number of immunoreactive-sites. In conclusion, the overproduction of nNOS and COX-2 in the kidney of OLETF rats was confirmed, suggesting that the overproduction of nNOS and/or COX-2 does not affect the intrarenal RAS or iNOS production but does affect TGF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508208     DOI: 10.1538/expanim.55.17

Source DB:  PubMed          Journal:  Exp Anim        ISSN: 0007-5124


  14 in total

1.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

2.  Rosiglitazone protects diabetic rats from liver destruction.

Authors:  Y-L Lu; T-T Ye; Y Chen; J Yu; L-J Zhao; N-J Wang; B-R Jiang; J Qiao; L-Z Yang
Journal:  J Endocrinol Invest       Date:  2011-07-25       Impact factor: 4.256

3.  Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.

Authors:  Magali Araujo; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

4.  p38 mediates mechanical allodynia in a mouse model of type 2 diabetes.

Authors:  Hsinlin T Cheng; Jacqueline R Dauch; Sang Su Oh; John M Hayes; Yu Hong; Eva L Feldman
Journal:  Mol Pain       Date:  2010-05-19       Impact factor: 3.395

5.  Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy.

Authors:  Shinichi Okada; Motoaki Saito; Emi Kazuyama; Takuya Hanada; Yasuo Kawaba; Atsushi Hayashi; Keisuke Satoh; Susumu Kanzaki
Journal:  Mol Cell Biochem       Date:  2008-06-05       Impact factor: 3.396

6.  Antioxidant diet and sex interact to regulate NOS isoform expression and glomerular mesangium proliferation in Zucker diabetic rat kidney.

Authors:  Yuriy Slyvka; Ramiro Malgor; Sharon R Inman; Julia Ding; Victor Heh; Felicia V Nowak
Journal:  Acta Histochem       Date:  2016-01-18       Impact factor: 2.479

Review 7.  Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Noriaki Nagai; Yoshimasa Ito
Journal:  World J Diabetes       Date:  2013-12-15

Review 8.  Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review.

Authors:  Robert Klopfleisch
Journal:  BMC Vet Res       Date:  2013-06-21       Impact factor: 2.741

Review 9.  Rodent models of diabetic nephropathy: their utility and limitations.

Authors:  Munehiro Kitada; Yoshio Ogura; Daisuke Koya
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-11-14

10.  PPAR-α Agonist Fenofibrate Prevented Diabetic Nephropathy by Inhibiting M1 Macrophages via Improving Endothelial Cell Function in db/db Mice.

Authors:  Xiaomeng Feng; Xia Gao; Shuo Wang; Mengxiu Huang; Zhencheng Sun; Hengbei Dong; Haitian Yu; Guang Wang
Journal:  Front Med (Lausanne)       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.